{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:43:54Z","timestamp":1793321034163,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/R019991\/1"],"award-info":[{"award-number":["BB\/R019991\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/T008784\/1"],"award-info":[{"award-number":["BB\/T008784\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ebiom.2023.104523","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T20:18:43Z","timestamp":1678997923000},"page":"104523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4222-7898","authenticated-orcid":false,"given":"Jack E.","family":"Saunders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Gilbride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Dowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ulaszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3421-6243","authenticated-orcid":false,"given":"Victoria A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-654X","authenticated-orcid":false,"given":"Kelly","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hewson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Belij-Rammerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2023.104523_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/v8060164","article-title":"Genomic characterization of the genus nairovirus (family bunyaviridae)","volume":"8","author":"Kuhn","year":"2016","journal-title":"Viruses"},{"issue":"Pt 11","key":"10.1016\/j.ebiom.2023.104523_bib2","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.035105-0","article-title":"Recent advances in the molecular and cellular biology of bunyaviruses","volume":"92","author":"Walter","year":"2011","journal-title":"J\u00a0Gen Virol"},{"issue":"17","key":"10.1016\/j.ebiom.2023.104523_bib3","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1128\/JVI.00752-06","article-title":"Crimean-Congo hemorrhagic fever virus genomics and global diversity","volume":"80","author":"Deyde","year":"2006","journal-title":"J\u00a0Virol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104523_bib4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1099\/jgv.0.001485","article-title":"ICTV virus taxonomy profile: Nairoviridae","volume":"101","author":"Garrison","year":"2020","journal-title":"J\u00a0Gen Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104523_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3201\/eid1804.111374","article-title":"Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey","volume":"18","author":"Bodur","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104523_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/vbz.2012.1061","article-title":"Pathogenesis of Crimean-Congo hemorrhagic fever","volume":"13","author":"Ak\u0131nc\u0131","year":"2013","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4314\/ahs.v19i1.16","article-title":"Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014\u20132017","volume":"19","author":"Gozdas","year":"2019","journal-title":"Afr Health Sci"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104523_bib9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jmv.23922","article-title":"Clinical symptoms and laboratory findings supporting early diagnosis of Crimean-Congo hemorrhagic fever in Iran","volume":"86","author":"Mostafavi","year":"2014","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ebiom.2023.104523_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101429","article-title":"New aspects about Crimean-Congo hemorrhagic fever (CCHF) cases and associated fatality trends: a global systematic review and meta-analysis","volume":"69","author":"Nasirian","year":"2020","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104523_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"Erg\u00f6n\u00fcl","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnx244","article-title":"Vector-borne diseases and climate change: a European perspective","volume":"365","author":"Semenza","year":"2018","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ebiom.2023.104523_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.meegid.2017.04.017","article-title":"Crimean-Congo hemorrhagic fever virus in ticks in Turkey: a broad range tick surveillance study","volume":"52","author":"Orkun","year":"2017","journal-title":"Infect Genet Evol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3201\/eid1801.111040","article-title":"Crimean-Congo hemorrhagic fever virus in ticks, Southwestern Europe, 2010","volume":"18","author":"Estrada-Pe\u00f1a","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004210","article-title":"Seroepidemiological studies of Crimean-Congo hemorrhagic fever virus in domestic and wild animals","volume":"10","author":"Spengler","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","article-title":"Crimean-Congo hemorrhagic fever","volume":"64","author":"Whitehouse","year":"2004","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijid.2008.07.021","article-title":"The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002\u20132007","volume":"13","author":"Yilmaz","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104523_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2017.05.010","article-title":"The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: a review of published field and laboratory studies","volume":"144","author":"Gargili","year":"2017","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104523_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/pathogens10040442","article-title":"World Health Organization high priority pathogens: ophthalmic disease findings and vision Health perspectives","volume":"10","author":"Kuthyar","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ebiom.2023.104523_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2023.104523_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2017.02.018","article-title":"Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions","volume":"58","author":"Al-Abri","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104523_bib22","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3390\/microorganisms9091907","article-title":"Crimean-Congo hemorrhagic fever virus in Asia, Africa and Europe","volume":"9","author":"Shahhosseini","year":"2021","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa1615162","article-title":"Autochthonous Crimean-Congo hemorrhagic fever in Spain","volume":"377","author":"Negredo","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2020.101555","article-title":"New geographical area on the map of Crimean-Congo hemorrhagic fever virus: first serological evidence in the Hungarian population","volume":"12","author":"Magyar","year":"2021","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.ebiom.2023.104523_bib25","series-title":"Open forum infectious diseases","article-title":"Ribavirin in treatment of Crimean-Congo hemorrhagic fever (CCHF): an international multicenter retrospective analysis","year":"2016"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104523_bib26","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/infdis\/jiy163","article-title":"Ribavirin had demonstrable effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) population and load in a patient with CCHF infection","volume":"217","author":"Espy","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"8973","key":"10.1016\/j.ebiom.2023.104523_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(95)91323-8","article-title":"Crimean Congo-haemorrhagic fever treated with oral ribavirin","volume":"346","author":"Fisher-Hoch","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib28","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.ijid.2010.09.009","article-title":"Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever","volume":"15","author":"Bodur","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/biores.2019.0057","article-title":"Crimean-Congo hemorrhagic fever virus: advances in vaccine development","volume":"9","author":"Tipih","year":"2020","journal-title":"Biores Open Access"},{"issue":"44","key":"10.1016\/j.ebiom.2023.104523_bib30","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1016\/j.vaccine.2012.08.003","article-title":"Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine","volume":"30","author":"Mousavi-Jazi","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib31","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.1038\/s41598-019-44210-6","article-title":"Vesicular stomatitis virus-based vaccine protects mice\u00a0against Crimean-Congo hemorrhagic fever","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/21645515.2015.1078045","article-title":"A\u00a0Crimean-Congo Hemorrhagic Fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease","volume":"12","author":"Dowall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01568-21","article-title":"Nucleoside-modified mRNA vaccines protect IFNAR(-\/-) mice against Crimean-Congo hemorrhagic fever virus infection","volume":"96","author":"Appelberg","year":"2022","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-021-00293-9","article-title":"A\u00a0CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice","volume":"6","author":"Suschak","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","article-title":"A\u00a0DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model","volume":"6","author":"Hawman","year":"2021","journal-title":"Nat Microbiol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104523_bib36","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1080\/21645515.2017.1383575","article-title":"Chimpanzee adenoviral vectors as vaccines for outbreak pathogens","volume":"13","author":"Ewer","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ebiom.2023.104523_bib37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2020.00909","article-title":"Factors which contribute to the immunogenicity of non-replicating adenoviral vectored vaccines","volume":"11","author":"Coughlan","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"10269","key":"10.1016\/j.ebiom.2023.104523_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003865","article-title":"Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: a randomised, placebo-controlled, multicentre phase II clinical trial","volume":"19","author":"Anywaine","year":"2022","journal-title":"PLoS Med"},{"issue":"25","key":"10.1016\/j.ebiom.2023.104523_bib41","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104523_bib42","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?","volume":"10","author":"Fausther-Bovendo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104523_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040385","article-title":"A\u00a0novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104523_bib44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/fvl-2016-0070","article-title":"Simian adenoviruses as vaccine vectors","volume":"11","author":"Morris","year":"2016","journal-title":"Future Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/vaccines7020040","article-title":"Safety and immunogenicity of a novel recombinant simian adenovirus ChAdOx2 as a vectored vaccine","volume":"7","author":"Folegatti","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"10342","key":"10.1016\/j.ebiom.2023.104523_bib46","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(22)00770-X","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6\u201317 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"10304","key":"10.1016\/j.ebiom.2023.104523_bib47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(21)01699-8","article-title":"Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)","volume":"398","author":"Flaxman","year":"2021","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ebiom.2023.104523_bib48","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","article-title":"Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination","volume":"30","author":"Verheust","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104523_bib49","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/v6072735","article-title":"Modified vaccinia virus Ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases","volume":"6","author":"Altenburg","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2023.104523_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coi.2016.05.014","article-title":"Viral vectors as vaccine platforms: from immunogenicity to impact","volume":"41","author":"Ewer","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"39","key":"10.1016\/j.ebiom.2023.104523_bib51","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.vaccine.2013.03.021","article-title":"Recombinant MVA vaccines: dispelling the myths","volume":"31","author":"Cottingham","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2023.104523_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified vaccinia virus Ankara: history, value in basic research, and current perspectives for vaccine development","volume":"97","author":"Volz","year":"2017","journal-title":"Adv Virus Res"},{"issue":"39","key":"10.1016\/j.ebiom.2023.104523_bib53","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2013.05.091","article-title":"Utilizing poxviral vectored vaccines for antibody induction\u2014progress and prospects","volume":"31","author":"Draper","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091516","article-title":"A\u00a0novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model","volume":"9","author":"Buttigieg","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104523_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156637","article-title":"Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses","volume":"11","author":"Dowall","year":"2016","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104523_bib56","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1128\/JVI.76.14.7263-7275.2002","article-title":"Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus","volume":"76","author":"Sanchez","year":"2002","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2013.05.030","article-title":"Crimean\u2013Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway","volume":"444","author":"Garrison","year":"2013","journal-title":"Virology"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104523_bib58","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","article-title":"Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever","volume":"184","author":"Fels","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2023.104523_bib59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2017.08.014","article-title":"Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus","volume":"146","author":"Zivcec","year":"2017","journal-title":"Antiviral Res"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104523_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004259","article-title":"Assessment of inhibitors of pathogenic Crimean-Congo hemorrhagic fever virus strains using virus-like particles","volume":"9","author":"Zivcec","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104523_bib61","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1089\/vbz.2011.0770","article-title":"Development of a real-time RT-PCR assay for the detection of Crimean-Congo hemorrhagic fever virus","volume":"12","author":"Atkinson","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.ebiom.2023.104523_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103902","article-title":"The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies","volume":"77","author":"Spencer","year":"2022","journal-title":"eBioMedicine"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/tropicalmed5030113","article-title":"Towards a sustainable one Health approach to Crimean-Congo hemorrhagic fever prevention: focus areas and gaps in knowledge","volume":"5","author":"Sorvillo","year":"2020","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104523_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.629636","article-title":"The integration of human and veterinary studies for better understanding and management of Crimean-Congo haemorrhagic fever","volume":"12","author":"Gilbride","year":"2021","journal-title":"Front Immunol"},{"issue":"7890","key":"10.1016\/j.ebiom.2023.104523_bib65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-04120-y","article-title":"Immunogenicity and efficacy\u00a0of heterologous ChAdOx1\u2013BNT162b2 vaccination","volume":"600","author":"Pozzetto","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104523_bib66","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104523_bib67","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/infdis\/jiy639","article-title":"Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal","volume":"219","author":"Venkatraman","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"30","key":"10.1016\/j.ebiom.2023.104523_bib68","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2017.05.032","article-title":"ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice","volume":"35","author":"Alharbi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2023.104523_bib69","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","article-title":"Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults","volume":"29","author":"Coughlan","year":"2018","journal-title":"eBioMedicine"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib70","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/vaccines8030346","article-title":"Heterologous combination of ChAdOx1 and MVA vectors expressing protein NS1 as vaccination strategy to induce durable and cross-protective CD8+ T cell immunity to bluetongue virus","volume":"8","author":"Utrilla-Trigo","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104523_bib71","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1469-0691.2006.01445.x","article-title":"Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited","volume":"12","author":"Ergonul","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ebiom.2023.104523_bib72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcv.2015.12.006","article-title":"Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: viral load","volume":"75","author":"Hasanoglu","year":"2016","journal-title":"J\u00a0Clin Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104523_bib73","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jiph.2019.04.005","article-title":"Persistence of IgG antibodies in survivors of Crimean Congo hemorrhagic fever virus infection, India","volume":"12","author":"Yadav","year":"2019","journal-title":"J\u00a0Infect Public Health"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104523_bib74","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.medmal.2019.09.005","article-title":"Crimean-Congo hemorrhagic fever: an update","volume":"49","author":"Fill\u00e2tre","year":"2019","journal-title":"Med Mal Infect"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104523_bib75","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but no protection in STAT1 knockout mice","volume":"15","author":"Kortekaas","year":"2015","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104523_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005908","article-title":"A\u00a0DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models","volume":"11","author":"Garrison","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2023.104523_bib77","doi-asserted-by":"crossref","first-page":"S801","DOI":"10.1093\/clinids\/11.Supplement_4.S801","article-title":"Antibody response in Crimean-Congo hemorrhagic fever","volume":"11","author":"Shepherd","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib78","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/s41467-021-23173-1","article-title":"Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice","volume":"12","author":"Spencer","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib79","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2021.02.001","article-title":"A\u00a0modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs","volume":"54","author":"Routhu","year":"2021","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104523_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006149","article-title":"Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection","volume":"11","author":"Goedhals","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib81","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/microorganisms9020279","article-title":"T-cells and interferon gamma are necessary for survival following Crimean-Congo hemorrhagic fever virus infection in mice","volume":"9","author":"Hawman","year":"2021","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104523_bib82","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","article-title":"Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins","volume":"79","author":"Bertolotti-Ciarlet","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbrc.2011.06.109","article-title":"Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor","volume":"411","author":"Xiao","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104523_bib84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/v8040106","article-title":"Molecular insights into crimean-Congo hemorrhagic fever virus","volume":"8","author":"Zivcec","year":"2016","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib85","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/v13020353","article-title":"Recent advances in bunyavirus glycoprotein research: precursor processing, receptor binding and structure","volume":"13","author":"Hulswit","year":"2021","journal-title":"Viruses"},{"issue":"6576","key":"10.1016\/j.ebiom.2023.104523_bib86","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.abl6502","article-title":"Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies","volume":"375","author":"Mishra","year":"2022","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104523_bib87","doi-asserted-by":"crossref","first-page":"e1008850","DOI":"10.1371\/journal.ppat.1008850","article-title":"The interplays between Crimean-Congo Hemorrhagic Fever Virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity","volume":"16","author":"Freitas","year":"2020","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104523_bib88","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.virol.2006.11.023","article-title":"N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport","volume":"361","author":"Erickson","year":"2007","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib89","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.coviro.2013.04.007","article-title":"Vaccines for viral hemorrhagic fevers--progress and shortcomings","volume":"3","author":"Falzarano","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104523_bib90","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02076-16","article-title":"Immunization with DNA plasmids coding for Crimean-Congo hemorrhagic fever virus capsid and envelope proteins and\/or virus-like particles induces protection and survival in challenged mice","volume":"91","author":"Hinkula","year":"2017","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104523_bib91","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/vaccines7030115","article-title":"Immunological analysis of a CCHFV mRNA vaccine candidate in mouse models","volume":"7","author":"Aligholipour Farzani","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib92","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/22221751.2019.1601030","article-title":"Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice","volume":"8","author":"Scholte","year":"2019","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104523_bib93","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/pathogens8040231","article-title":"A\u00a0single and un-adjuvanted dose of a\u00a0chimpanzee adenovirus-vectored vaccine against chikungunya virus fully protects mice from lethal disease","volume":"8","author":"Campos","year":"2019","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104523_bib94","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/s41467-021-24906-y","article-title":"A\u00a0single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial","volume":"12","author":"Folegatti","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2023.104523_bib95","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-017-0029-1","article-title":"Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model","volume":"2","author":"Munster","year":"2017","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104523_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007462","article-title":"A\u00a0single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters","volume":"13","author":"van Doremalen","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"24","key":"10.1016\/j.ebiom.2023.104523_bib97","doi-asserted-by":"crossref","first-page":"eaba8399","DOI":"10.1126\/sciadv.aba8399","article-title":"A\u00a0single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques","volume":"6","author":"van Doremalen","year":"2020","journal-title":"Sci Adv"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:22:21Z","timestamp":1762456941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":97,"alternative-id":["S2352396423000889"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104523","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104523"}}